<resource xmlns:datacite="http://datacite.org/schema/kernel-4">
<creators>
<creator>
<creatorName nameType="Personal">Chloe Puget</creatorName>
<givenName>Chloe</givenName>
<familyName>Puget</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Jonathan Ganz</creatorName>
<givenName>Jonathan</givenName>
<familyName>Ganz</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Christof A. Bertram</creatorName>
<givenName>Christof A.</givenName>
<familyName>Bertram</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Thomas Conrad</creatorName>
<givenName>Thomas</givenName>
<familyName>Conrad</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Malte Baeblich</creatorName>
<givenName>Malte</givenName>
<familyName>Baeblich</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Anne Voss</creatorName>
<givenName>Anne</givenName>
<familyName>Voss</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Katharina Landmann</creatorName>
<givenName>Katharina</givenName>
<familyName>Landmann</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Alexander F. H. Haake</creatorName>
<givenName>Alexander F. H.</givenName>
<familyName>Haake</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Andreas Spree</creatorName>
<givenName>Andreas</givenName>
<familyName>Spree</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Svenja Hartung</creatorName>
<givenName>Svenja</givenName>
<familyName>Hartung</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Leonore Aeschlimann</creatorName>
<givenName>Leonore</givenName>
<familyName>Aeschlimann</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Sara Soto</creatorName>
<givenName>Sara</givenName>
<familyName>Soto</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Simone de Brot</creatorName>
<givenName>Simone</givenName>
<familyName>de Brot</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Martina Dettwiler</creatorName>
<givenName>Martina</givenName>
<familyName>Dettwiler</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Heike Aupperle-Lellbach</creatorName>
<givenName>Heike</givenName>
<familyName>Aupperle-Lellbach</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Pompei Bolfa</creatorName>
<givenName>Pompei</givenName>
<familyName>Bolfa</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Alexander Bartel</creatorName>
<givenName>Alexander</givenName>
<familyName>Bartel</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Matti Kiupel</creatorName>
<givenName>Matti</givenName>
<familyName>Kiupel</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Katharina Breininger</creatorName>
<givenName>Katharina</givenName>
<familyName>Breininger</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Marc Aubreville</creatorName>
<givenName>Marc</givenName>
<familyName>Aubreville</familyName>
</creator>
<creator>
<creatorName nameType="Personal">Robert Klopfleisch</creatorName>
<givenName>Robert</givenName>
<familyName>Klopfleisch</familyName>
</creator>
</creators>
<titles>
<title>Artificial intelligence predicts c-KIT exon 11 genotype by phenotype in canine cutaneous mast cell tumors: Can human observers learn it?</title>
</titles>
<publisher>Sage Publications Inc</publisher>
<publicationYear>2025</publicationYear>
<descriptions>
<description descriptionType="Other">Canine cutaneous mast cell tumors (ccMCTs) are frequent neoplasms with variable biological behaviors. Internal tandem duplication mutations in c-KIT exon 11 (c-KIT-11-ITD) are associated with poor prognosis but predict therapeutic response to tyrosine kinase inhibitors. In a previous work, deep learning algorithms managed to predict the presence of c-KIT-11-ITD on digitalized hematoxylin and eosin-stained histological slides (whole-slide images, WSIs) in up to 87% of cases, suggesting the existence of morphological features characterizing ccMCTs carrying c-KIT-11-ITD. This 3-stage blinded study aimed to identify morphological features indicative of c-KIT-11-ITD and to evaluate the ability of human observers to learn this task. 17 untrained pathologists first classified 8 WSIs and 200 image patches (highly relevant for algorithmic classification) of ccMCTs as either positive or negative for c-KIT-11-ITD. Second, they self-trained to recognize c-KIT-11-ITD by looking at the same WSIs and patches correctly sorted. Third, pathologists classified 15 new WSIs and 200 new patches according to c-KIT-11-ITD status. In addition, participants reported microscopic features they considered relevant for their decision. Without training, participants correctly classified the c-KIT-11-ITD status of 63%–88% of WSIs and 43%–55% of patches. With self-training, 25%–38% of WSIs and 55%–56% of patches were correctly classified. High cellular pleomorphism, anisokaryosis, and sparse cytoplasmic granulation were commonly suggested as features associated with c-KIT-11-ITD-positive ccMCTs, none of which showed reliable predictivity in a follow-up study. The results indicate that transfer of algorithmic skills to the human observer is difficult. A c-KIT-11-ITD-specific morphological feature remains to be extracted from the artificial intelligence model.</description>
<description descriptionType="Other">Online Version of Record before inclusion in an issue</description>
</descriptions>
<resourceType resourceTypeGeneral="Text">PDFDocument</resourceType>
<language>eng</language>
<dates>
<date dateType="Created">2025-11-28T08:50:40.899920Z</date>
<date dateType="Issued">2025</date>
</dates>
<subjects>
<subject>c-KIT</subject>
<subject>Digital Pathology</subject>
<subject>Deep Learning</subject>
<subject>Dog</subject>
<subject>Genotype Prediction</subject>
<subject>Mast Cell Tumor</subject>
<subject>Morphological Feature</subject>
<subject>Performance Study</subject>
</subjects>
<sizes>
<size>1951617 b</size>
</sizes>
<formats>
<format>application/pdf</format>
</formats>
<rightsList>
<rights rightsURI="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</rights>
</rightsList>
</resource>
